Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-05-09Clinical Trial Update: A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253) [Phase 1]
Phase 1 study evaluating bioequivalence of 70-mg alendronate alone and in combination with 5600 IU vitamin D (MK0217A-253) for osteoporosis;…
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Efficacy Study of Zoledronic Acid and Teriparatide Combination Therapy in Women With Osteoporosis [Phase 3]
A Phase 3 efficacy trial evaluated a combination of zoledronic acid and teriparatide in women with osteoporosis. Results were posted in 2011…
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Cohort Study on Associations Between Purinergic Receptor SNPs and Osteoporosis Risk
This cohort study examines whether purinergic receptor SNPs are associated with osteoporosis risk. It reports on genotype-osteoporosis assoc…
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Mechanical Bone Stimulation and Adenosine 5'-Triphosphate (ATP) Release in Humans [Phase 1, Phase 2]
Phase 1/2 clinical trial sponsored by Maastricht University Medical Center examined mechanical bone stimulation and ATP release in osteoporo…
-
CLINICAL_TRIALS research · 2011-04-13Clinical Trial Update: Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer [Phase 3]
A Phase 3 clinical trial update investigates osteoporosis risk among men with prostate cancer treated with androgen deprivation therapy; the…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-04-07Clinical Trial Update: Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis [Phase 3]
Phase 3 trial comparing tapentadol IR, oxycodone IR, and placebo for acute pain from vertebral compression fractures due to osteoporosis has…
-
FDA approval · 2011-04-06FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ALENDRONATE SODIUM from Aurobindo Pharma Limited, indicating approval of a supplemental submissi…
-
FDA approval · 2011-04-01FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for alendronate sodium filed by Amneal Pharmaceuticals of New York LLC. This action updates the regu…
-
CLINICAL_TRIALS trial_result · 2011-03-11Clinical Trial Update: Effects of Zoledronic Acid and Raloxifene on Bone Turnover Markers in Postmenopausal Women With Low Bone Mineral Density [Phase 4]
Phase 4 clinical trial assessing the effects of zoledronic acid and raloxifene on bone turnover markers in postmenopausal women with low bon…
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: The Importance of Patient Education - A Randomised Controlled Trial [EARLY_Phase 1]
A completed early-phase randomized trial evaluating the impact of patient education on adherence and quality of life in osteoporosis.
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer
This completed clinical trial evaluates whether tamoxifen can prevent bone loss and heart disease in premenopausal women receiving chemother…
-
FDA approval · 2011-02-15FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Alendronate sodium filed by Aurobindo Pharma Limited.
-
FDA label_change · 2011-01-25FDA Approved: ACTONEL — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Actonel (risendronate sodium) filed by Allergan, Inc., to update the labeling related to its app…
-
FDA approval · 2011-01-25FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Fosamax (alendronate sodium) submitted by Organon LLC.
-
FDA approval · 2011-01-25FDA Approved: FOSAMAX PLUS D — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Fosamax Plus D (alendronate sodium with cholecalciferol) from Organon LLC.
-
FDA approval · 2011-01-25FDA Approved: RECLAST — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for RECLAST (zoledronic acid) filed by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis [Phase 2]
Phase 2 trial evaluating the safety and efficacy of alendronate (Fosamax) in children with osteoporosis has completed and results have been …
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women [NA]
This completed clinical trial evaluated switching to intravenous zoledronic acid after teriparatide (Forteo) in postmenopausal osteoporosis;…
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment) [Phase 3]
The Phase 3 IMPACT study evaluating ACtonel for osteoporosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-11Clinical Trial Update: Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation [Phase 4]
A Phase 4 trial comparing risedronate and raloxifene for discontinuation of hormone replacement therapy in postmenopausal osteoporosis has b…
-
CLINICAL_TRIALS research · 2010-11-25Clinical Trial Update: Prevalence of Osteoporosis in Patients Who Uses Inhaled Steroids [NA]
This clinical trial update examines the prevalence of osteoporosis among patients using inhaled corticosteroids.
-
CLINICAL_TRIALS trial_result · 2010-11-23Clinical Trial Update: Metabolic Assessment of Aging Men With Urinary Lithiasis
This completed clinical trial evaluated metabolic factors in aging men with kidney stones, focusing on metabolic risk assessments.
-
FDA approval · 2010-11-18FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for PROLIA (denosumab) filed by Amgen.
-
CLINICAL_TRIALS trial_result · 2010-11-03Clinical Trial Update: Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer
A completed Sanofi-sponsored trial evaluating bisphosphonate therapy for osteopenia/osteoporosis in men with prostate cancer, emphasizing tr…
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: A School-Based Osteoporosis Prevention Program for Adolescent Girls [Phase 1]
This Phase 1 clinical trial evaluated a school-based osteoporosis prevention program for adolescent girls and has completed. The study was s…